However, further research is necessary to determine the precise mechanisms behind the increased endogenous production of GLP‐1 in individuals with sarcopenia and to assess whether GLP‐1R agonists influence kinesin‐1 activity in skeletal muscle cells. Here, GLP1R is linked to sarcopenia.